Neuroscience
ACE Inhibitor
20%
Adrenergic Receptor
20%
Angiotensin
80%
Angiotensin II Receptor Antagonist
20%
Arginine Methyl Ester
100%
Calcium Channel Blocker
20%
Eicosanoid
20%
Enalapril
40%
Endothelin
100%
H2 Antagonist
20%
Losartan
40%
Nicardipine
40%
Nitric Oxide
20%
Prazosin
20%
Pressor Response
100%
Prostaglandin
20%
Renin
80%
Thromboxane A2
60%
Vasoactive
100%
Vasoconstrictors
60%
Pharmacology, Toxicology and Pharmaceutical Science
Adrenergic Receptor
16%
Angiotensin
66%
Angiotensin Receptor Antagonist
16%
Arginine Methyl Ester
100%
Calcium Channel Blocker
16%
Dipeptidyl Carboxypeptidase Inhibitor
16%
Enalapril
33%
Endothelin
83%
Histamine H2 Receptor Antagonist
16%
Hypertensive Factor
100%
Icosanoid
16%
Indometacin
33%
Losartan
33%
Nicardipine
33%
Nitric Oxide
16%
Phosphoramidon
33%
Prazosin
16%
Prostaglandin H2
16%
Renin
66%
Sodium Chloride
16%
Thromboxane A2
50%
Wistar Rat
16%
Keyphrases
Adrenoceptors
9%
Angiotensin Receptor Antagonists
9%
Angiotensin-converting Enzyme Inhibitor (ACEi)
9%
Attenuation
9%
Beta-blockers
9%
Calcium Channel Blockers
9%
Chronic Treatment
9%
Dependent Product
9%
Dietary Sodium Restriction
9%
DOCA-salt
9%
Eicosanoids
9%
Enalapril
18%
Endothelin-1 (ET-1)
45%
H2-receptor Antagonists
9%
Indomethacin
18%
L-NAME
100%
Losartan
18%
Low-sodium Diet
9%
Mean Arterial Pressure
9%
Nicardipine
18%
Nitric Oxide Production
9%
Nonapeptides
9%
Phosphoramidon
18%
Prazosin
9%
Pressor Effect
100%
Pressor Response
9%
Prostaglandin H2
9%
Renin-angiotensin System
36%
Salt Pretreatment
9%
Uninephrectomy
9%
Vasoactive Systems
100%
Vasodilator
27%
Vasopressors
9%
Wistar Rats
9%